From the Leeds Institute of Health Sciences, University of Leeds, UK (SHB); Department of Family Medicine, University of Washington, Seattle (MJT); Nuffield Department of Primary Care Health Sciences, University of Oxford, UK (BDN).
J Am Board Fam Med. 2021 Mar-Apr;34(2):435-438. doi: 10.3122/jabfm.2021.02.200353.
The history of cancer screening has demonstrated that the case for cancer screening is not straightforward. In contemporary practice, sharing decision-making with patients has become expected of family physicians. At the same time, increasing emphasis has been placed on encouraging patients to participate in screening programs to improve cancer outcomes. The success of cancer screening is often judged by the number of those who participate. Improving cancer outcomes should be a priority for family medicine, but the importance of this goal should not undermine doctors' commitment to helping patients make informed decisions that are consistent with their values and priorities. If we are serious about empowering patients, we need to be more open about the limitations of cancer screening, to help patients make up their minds.
癌症筛查的历史表明,癌症筛查的理由并不简单。在当代实践中,与患者共同做出决策已成为家庭医生的期望。与此同时,越来越强调鼓励患者参与筛查计划以改善癌症结果。癌症筛查的成功通常取决于参与人数。改善癌症结果应该是家庭医学的优先事项,但这一目标的重要性不应削弱医生帮助患者做出符合其价值观和优先事项的知情决策的承诺。如果我们认真对待赋予患者权力,我们就需要更坦诚地面对癌症筛查的局限性,以帮助患者下定决心。